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Functional macrophage heterogeneity is recognized outside the central nervous system
(CNS), where alternatively activated macrophages can perform immune-resolving
functions. Such functional heterogeneity was largely ignored in the CNS, with respect to
the resident microglia and the myeloid-derived cells recruited from the blood following
injury or disease, previously deﬁned as blood-derivedmicroglia; bothwere indistinguishably
perceived detrimental. Our studies have led us to view the myeloid-derived inﬁltrating
cells as functionally distinct from the resident microglia, and accordingly, to name
them monocyte-derived macrophages (mo-MΦ). Although microglia perform various
maintenance and protective roles, under certain conditions when they can no longer
provide protection, mo-MΦ are recruited to the damaged CNS; there, they act not as
microglial replacements but rather assistant cells, providing activities that cannot be
timely performed by the resident cells. Here, we focus on the functional heterogeneity
of microglia/mo-MΦ, emphasizing that, as opposed to the mo-MΦ, microglia often fail to
timely acquire the phenotype essential for CNS repair.
Keywords: microglia, monocytes, CNS, innate, resolution of inflammation, macrophages, neuroprotection,
monocyte-derived macrophages
INTRODUCTION
Outside the central nervous system (CNS), macrophages are
known to acquire distinct phenotypes, and accordingly, per-
form various different and even opposing functions. Macrophages
are generally polarized into two major phenotypes: Th1-related
cytokines, such as interferon-gamma (IFN-γ), and microbial chal-
lenge by products such as lipopolysaccharides (LPS) induce the
classically activated M1 phenotype, driving macrophages toward a
pro-inﬂammatory microbicidal function, whereas Th2 cytokines,
such as interleukin-4 (IL-4) and IL-13 polarize macrophages to
an alternatively activated M2 phenotype associated with wound
healing and immune resolution (Gordon, 2003; Gordon and Tay-
lor, 2005; Mantovani et al., 2005; Mosser and Edwards, 2008;
Auffray et al., 2009; Martinez et al., 2009; Gordon and Martinez,
2010; Sica and Mantovani, 2012). These different macrophage
populations act following various insults outside the CNS where
the CCR2+CX3CR1lowLy6Chigh subset, corresponding to the M1
phenotype, is the ﬁrst recruited to the damage site and is typ-
ically pro-inﬂammatory, while the CCR2−CX3CR1highLy6Clow
cells, matching the M2 phenotype, subsequently terminate the
local inﬂammation as well as promoting regeneration and healing
(Arnold et al., 2007; Nahrendorf et al., 2007). These two polarized
phenotypes are further classiﬁed, based on their diverse sur-
face markers, phenotypes and functions, into a more continuum
spectrum of macrophage repertoire (Mosser and Edwards, 2008).
In the CNS, however, such diversity of macrophage func-
tions was largely overlooked, as microglia, the native immune
cells of the CNS, were considered its exclusive innate com-
ponents. Initially discovered by Cajal (1913) and his student
Del Rio-Hortega (1919), microglia are currently accepted as self-
renewing cells with a unique embryonic origin (Ginhoux et al.,
2010; Schulz et al., 2012; Gomez Perdiguero et al., 2013), dis-
tributed along CNS parenchymal tissues. Their primary roles are
the maintenance of normal CNS functions (Elkabes et al., 1996;
Nakajima et al., 2001; Aarum et al., 2003; Nimmerjahn et al., 2005;
Walton et al., 2006; Ziv et al., 2006; Ransohoff and Perry, 2009;
Wake et al., 2009; Sierra et al., 2010; Tremblay, 2011) and the
continuous search for alterations in homeostasis through their
constantly scanning dynamic ramiﬁcations (Nimmerjahn et al.,
2005; Hanisch and Kettenmann, 2007; Ransohoff and Perry,
2009; Kettenmann et al., 2011). Under pathological conditions,
microglial functions are largely dependent on their activation
stimuli; whereas moderate CNS damage evokes protection by
microglia (Prewitt et al., 1997; Rabchevsky and Streit, 1997; Batch-
elor et al., 1999; Chung et al., 1999; Butovsky et al., 2001; Kotter
et al., 2001; Stadelmannet al., 2002; Streit,2002; Shaked et al., 2004,
2005; Neumann et al., 2006, 2008; Schwartz et al., 2006; Yin et al.,
2006; Majumdar et al., 2007; Muzio et al., 2007; Thored et al., 2009;
Kettenmann et al., 2011), intensive acute activation (for example
in spinal cord injury, optic nerve crush, or stroke) and chronic
activation, which characterizes neurodegenerative diseases, ren-
der these cells neurotoxic, potentially impairing neuronal activity
(Munn, 2000; Stalder et al., 2001; Wegiel et al., 2001; Ekdahl et al.,
2003;Monje et al., 2003; Stirling et al., 2004; Block andHong,2005;
Heppner et al., 2005; Block et al., 2007; Hanisch and Kettenmann,
2007; Muzio et al., 2007; Ovanesov et al., 2008; Centonze et al.,
2009;Maezawa and Jin, 2010; Perry et al., 2010; Derecki et al., 2012,
2013; Scheffel et al., 2012). Such a phenotype not only prohibits
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microglia from resolving inﬂammatory damage but rather con-
tributes to the vicious cycle of toxicity and calls for additional
assistance to terminate the local inﬂammation.
As an immune privileged site, the CNS was, for decades, con-
sidered sealed for leukocyte entry, protected from the circulation
behind the walls of the blood–brain barrier (Wilson et al., 2010;
Ransohoff and Engelhardt, 2012). Any recruitment of immune
cells to the CNS was perceived as either a technical artifact (Ajami
et al., 2007; Mildner et al., 2007) or as part of the ongoing inﬂam-
matory damage (McGeer et al., 1990; Popovich et al., 1999; Gris
et al., 2004; Stirling et al., 2004; Boster et al., 2008). Further con-
fusion resulted from the fact that blood-derived myeloid cells,
recruited following CNS damage, were considered microglial rein-
forcements of comparable functions, and were accordingly termed
“blood-derived microglia” (Eglitis and Mezey, 1997; Priller et al.,
2001; Bechmann et al., 2005; Simard et al., 2006). A series of recent
innovative studies demonstrated that such inﬁltrating cells, which
wedeﬁned asmonocyte-derivedmacrophages (mo-MΦ), perform
indispensable roles that cannot be provided by their resident coun-
terparts (Shechter et al., 2009, 2011; London et al., 2011). These
studies challenged the traditional perception of macrophages in
the CNS as a functionally homogeneous population. Moreover,
they set the ground for a new era of research employing sophisti-
cated techniques including parabiosis, head-protected bone mar-
row chimeras, transgenic mice, and fate mapping analysis (Carson
et al., 2007; Ginhoux et al., 2010; Saederup et al., 2010; Ajami
et al., 2011; Mildner et al., 2011; Prinz et al., 2011; Butovsky et al.,
2012; Derecki et al., 2012; Schulz et al., 2012; Colton, 2013; Gomez
Perdiguero et al., 2013), aimed at revealing the differential origin,
phenotype, and function of distinct myeloid populations within
theCNS. In this perspective,wewill focus on the functional hetero-
geneity of microglia/mo-MΦ, addressing microglial functions as
theﬁrst immunological support, the failure of these cells to provide
signiﬁcant protection under intensive acute or chronic activation,
and the subsequent unique contribution of the mo-MΦ.
MICROGLIA IN MAINTENANCE AND DEFENSE
Similar to other tissue-resident macrophages outside the CNS,
the primary role of microglia is to support normal tissue func-
tion, in this case neuronal integrity (Nimmerjahn et al., 2005;
Hanisch and Kettenmann, 2007; Ransohoff and Perry, 2009; Ket-
tenmann et al., 2011; Scheffel et al., 2012). The development of
in vivo two-photon microscopy revolutionized our understand-
ing of microglial functions under steady state. It allowed the
study of non-activated microglia in intact brains of living ani-
mals (Davalos et al., 2005; Hanisch and Kettenmann, 2007). In
these studies, usingCx3cr1GFP/+ or Iba1-EGFP transgenicmice, in
which microglia are ﬂuorescently labeled (Jung et al., 2000; Hira-
sawa et al., 2005), these cells present highlymotile processes, which
directly contact astrocytes, neurons, and blood vessels, allowing
the microglia to perform surveillance functions, constantly sens-
ing subtle changes in their microenvironment (Nimmerjahn et al.,
2005). Microglia provide several housekeeping functions. For
instance, these cells are involved in the maintenance of synapses;
microglial ramiﬁcations directly interact with termini, spines,
astrocytic processes, and synaptic clefts (Murabe and Sano, 1982;
Wake et al., 2009; Tremblay, 2011). These interactions enable the
recognition of neuronal activity or structural alterations, accord-
ing to which microglia facilitate synapse elimination, pruning
or maturation, thereby preserve and organize neuronal networks
(Murabe and Sano, 1982; Wake et al., 2009; Paolicelli et al., 2011;
Tremblay, 2011). Microglia have been reported to support neu-
rogenesis; they rapidly and efﬁciently clear out, by phagocytosis,
the numerous apoptotic neural progenitor cells (NPCs) that do
not incorporate into the circuitry (Sierra et al., 2010), direct the
migration and differentiation of NPCs, as well as secreting solu-
ble factors promoting neurogenesis (Aarum et al., 2003; Butovsky
et al., 2006c; Walton et al., 2006; Choi et al., 2008). Moreover,
microglial activation following exercise and by local interaction
with adaptive immune cells strongly supports neurogenesis and
enhances cognitive functions (Ziv et al., 2006; Ziv and Schwartz,
2008; Wolf et al., 2009; Vukovic et al., 2012). Additionally, several
in vitro and in vivo studies demonstrated the capacity of microglia
to secrete neurotrophic factors, e.g., nerve growth factor (NGF),
neurotrophin-3 (NT-3), and NT-4 (Elkabes et al., 1996; Naka-
jima et al., 2001). Under certain conditions microglia upregulate
their brain-derived neurotrophic factor (BDNF) and insulin-like
growth factor-1 (IGF-1) expression; both factors have protective
and growth-promoting effects and are essential for learning and
memory skills (Mizuno et al., 2000; Hsieh et al., 2004; Lee et al.,
2004; Butovsky et al., 2006c; Wang et al., 2012).
Being the native immune cells of the CNS, microglia act as
the ﬁrst line of defense, protecting the CNS from invading agents
as well as internal enemies; microglia are involved in infection,
inﬂammation, autoimmune disease, trauma, ischemia, and neu-
rodegeneration. After initial exposure to a danger signal,microglia
become activated; they upregulate expression levels of certain
molecules such as CD11b and Iba1, and gain expression of
molecules associated with antigen presentation, such as major
histocompatibility complex (MHC)-II, B7.1, and B7.2 (CD80/86),
which are absent in naïve microglia. Microglia then lose their
ramiﬁed morphology and surveillance mode, and convert to
amoeboid-like, functional cells (Kettenmann et al., 2011).
Microglial functions under pathological conditions may reﬂect
their diverse phenotypes acquired contingent to their activation
signals. For example, activation of microglia by T cells that recog-
nize CNS antigens or T cell-derived cytokines such as IFN-γ (at
low concentrations) and IL-4 supports differentiation of NPCs
and provides neuroprotection by regulating IGF-1 and tumor
necrosis factor-alpha (TNF-α) levels. However, stimulation with
LPS, amyloid-β or high concentrations of IFN-γ diminishes these
effects. Moreover, activation of microglia by IL-4 prior to the
LPS stimulation prevents the LPS-mediated-inhibition of the
microglial neuroprotective effects (Avidan et al., 2004; Shaked
et al., 2004; Butovsky et al., 2005, 2006a,b,c; Scheffel et al., 2012).
Thus, microglia are highly versatile cells; their regulated activation
and proper termination might help in tissue preservation, repair,
and renewal, while intensive acute or chronic activation may result
in irreversible tissue loss.
Microglia exert several protective roles. These include removal
by phagocytosis of pathogens and microbes, as well as clearance
of toxic molecules, cell debris, remains of extracellular matrix,
myelin derivatives, and protein deposits (e.g., amyloid-β or p-
tau), all of which further contribute to the local inﬂammation
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and are inhibitory to regeneration and repair (Chung et al.,
1999; Magnus et al., 2001; Ravichandran, 2003; Shaked et al.,
2005; Liu et al., 2006; Majumdar et al., 2007; Kettenmann et al.,
2011). Microglia can promote regeneration; other than removal
of growth-inhibitory compounds (Kettenmann et al., 2011), these
cells produce classical growth factors required for remyelination
and regeneration (Kotter et al., 2001; Stadelmann et al., 2002).
Microglia were reported to support regeneration of the optic nerve
as well as sensory axons in the injured spinal cord (Prewitt et al.,
1997; Rabchevsky and Streit, 1997; Yin et al., 2006) and to induce
dopaminergic sprouting in the injured striatum (Batchelor et al.,
1999). Additionally, microglia were shown to support neurogen-
esis and reduce neuronal death following stroke (Neumann et al.,
2006; Thored et al., 2009).
MICROGLIAL MALFUNCTION FOLLOWING INTENSIVE ACUTE
OR CHRONIC ACTIVATION – A CALL FOR PERIPHERAL HELP
Substantial evident suggest that microglial activity is not always
optimal and is often not sufﬁcient to support signiﬁcant CNS
repair; on the contrary in many cases their insufﬁcient support
turns detrimental. Under intensive acute or chronic activation,
microglia not only fail to provide the needed functions, but there
are ample evidence implying that they can be actively deleterious;
these cells secrete reactive oxygen species, nitric oxide (NO), and
pro-inﬂammatory cytokines that can endanger neurons, oligo-
dendrocytes, or essential structures of the extracellular matrix
(Monje et al., 2003; Stirling et al., 2004; Block and Hong, 2005;
Block et al., 2007; Hanisch and Kettenmann, 2007; Perry et al.,
2010). Microglial malfunction was suggested as a possible eti-
ology in schizophrenia, resulting in impaired pruning during
neurodevelopment, disturbanceof normal neurotransmitter func-
tion, and uncontrolled production of pro-inﬂammatory cytokines
such as TNF and IL-6, as well as failure in clearance of neuronal
corpses (Munn, 2000). Microglial abnormal response is also evi-
dent in Rett syndrome, a neurodevelopmental disease resulting
from mutation of the gene encoding methyl-CpG binding protein
(Mecp2). Mecp2-null microglia release glutamate at neurotoxic
levels (Maezawa and Jin, 2010) and have impaired phagocytic
activity (Derecki et al., 2012, 2013), possibly contributing to dis-
ease development. Impairedmicroglial function is also reported in
amyotrophic lateral sclerosis (ALS), where microglia derived from
mutant superoxide dismutase 1 (SOD1)mouse, an established dis-
ease model of ALS, induce more oxidative stress and cause higher
neuronal loss compared with wt microglia (Beers et al., 2006).
Interestingly, down regulation of the mutant levels in microglia
results in reduced disease progression (Boillée et al., 2006). In
experimental autoimmune encephalomyelitis (EAE), a neurode-
generative disease model, microglial activation was inhibited by
administration of ganciclovir to chimeric mice in which only the
microglia express thymidine kinase that converts this drug into its
cytotoxic form. Such speciﬁc microglial paralysis inhibits disease
development and attenuates inﬂammatory CNS lesions (Heppner
et al., 2005). Moreover, in Alzheimer’s disease, characterization
of ﬁbrillar plaque development in brains of transgenic APP(SW)
mice revealed thatmicroglia are not only unable to clear amyloid-β
deposits, but rather, contribute to plaque formation (Stalder et al.,
2001; Wegiel et al., 2001). Additionally, microglia-derived chronic
inﬂammation was shown to precede neuronal loss in neonatal
borna disease virus (BDV) infection (Ovanesov et al., 2008).
Collectively, these evident suggest that under intensive acute or
chronic activation microglia fail to acquire the desired phenotype,
lose their essential functions and turn actively deleterious, and thus
cannot provide immune resolution and subsequent CNS protec-
tion. In such scenarios, the recruitment of additional myeloid cells
from the blood, comparable to microglia, is not likely. Rather,
there is a need for peripheral intervention, in the form of unique
cells, capable of providing the functions that cannot be delivered
by the resident microglia.
FUNCTIONAL MACROPHAGE HETEROGENEITY
Indeed, intensive acute or chronic microglial activation drives
these cells to produce a chemoattractive proﬁle favoring the
recruitment of monocytes and lymphocytes (Hausler et al., 2002;
Sargsyan et al., 2009; Okamura et al., 2012). However, as the CNS
is an immune privileged site, it was assumed to exclude leuko-
cyte trafﬁcking (Wilson et al., 2010; Ransohoff and Engelhardt,
2012). Consequently, several studies suggested that the recruit-
ment of myeloid cells to the CNS reﬂected non-physiological
entry, imposed by the unnatural experimental model (Ajami et al.,
2007; Mildner et al., 2007). Other studies, although recognizing
leukocyte entry to the CNS, interpreted their presence as a sign
of pathology or malfunction that is detrimental and should be
avoided (McGeer et al., 1990; Popovich et al., 1999; Gris et al.,
2004; Stirling et al., 2004; Boster et al., 2008). Moreover, the previ-
ous technical limited ability to distinguish between the inﬁltrating
blood-derived cells and the resident microglia resulted in the view
of the newly recruited cells as part of the microglial reservoir,
leading to their inaccurate tagging as “blood-derived microglia”
(Eglitis and Mezey, 1997; Priller et al., 2001; Bechmann et al.,
2005; Simard et al., 2006). This misleading nomenclature resulted
in the erroneous perception of these cells as phenotypically and
functionally comparable to microglia. Since then, advanced tech-
niques have been developed to allow the blood-derived cells to be
distinctly tracked and manipulated (Popovich and Hickey, 2001;
Wright et al., 2001; Carson et al., 2007; Rolls et al., 2008; Shechter
et al., 2009; Ajami et al., 2011; Colton, 2013). A series of recent
studies used head shielded [Cx3cr1GFP/+→WT] bone marrow
chimeric mice, whose wt bone marrow was replaced with that
of Cx3cr1GFP/+ mice (Jung et al., 2000). This approach allows
the inﬁltrating myeloid cells, derived from donor bone marrow
and labeled with GFP, to be distinguished from their resident
counterparts, while avoiding any artifacts related to brain irra-
diation (Shechter et al., 2009). These studies revealed the unique
and non-redundant functions of the newly recruited cells and
suggested the term “monocyte-derived macrophages (mo-MΦ)”
to identify these cells as an entity separate from the resident
microglia (Shechter et al., 2009, 2011; London et al., 2011). mo-
MΦ restrict amyloid-β plaques in a mouse model of Alzheimer’s
disease (Simard et al., 2006; Butovsky et al., 2007), contribute to
motor function recovery following spinal cord injury (Shechter
et al., 2009), promote survival of neurons and cell renewal in the
injured retina (London et al., 2011), and were recently shown
to arrest disease progression in Rett syndrome (Derecki et al.,
2012). These cells display immune-resolving characteristics and
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express anti-inﬂammatory cytokines, which are crucial for their
neuroprotective function. Moreover, they restrict accumulation
of other inﬂammatory leukocytes including neutrophils and resi-
dent microglia (Shechter et al., 2009; London et al., 2011), mediate
debris clearance by phagocytosis (Derecki et al., 2012), and reg-
ulate the extracellular matrix and glial scar surrounding the
damaged area (Shechter et al., 2011). Importantly, inhibition or
attenuation of the inﬁltration of mo-MΦ results in exacerbated
damage, indicating that the resident microglia, which were spared
in these experiments, cannot fulﬁll the protective functions pro-
vided by the mo-MΦ (Butovsky et al., 2007; Shechter et al., 2009,
2011; London et al., 2011).
Additional reinforcement for the disparity of these two myeloid
populations is the fact that resident microglia and mo-MΦ
development is dependent on different transcription factors.
While development of both microglia and mo-MΦ requires the
transcription factor, Pu.1 (McKercher et al., 1996), the latter
necessitates Myb and FLT3, whereas microglial development is
csf1-receptor-dependent and FLT3- and Myb-independent (Gin-
houx et al., 2010; Schulz et al., 2012; Gomez Perdiguero et al.,
2013). Each of these two myeloid populations has a unique set of
transcription factors and regulators leading to a diverse pattern of
gene expression. Advanced analysis methods compared the proﬁle
of gene expression, microRNAs (miRNAs) and transcription fac-
tors, of splenic Ly6Chi monocytes and CD39+ resident microglia
in the SOD1 mouse, and of CD14+CD16− peripheral monocytes
in ALS patients (Butovsky et al., 2012). In this study, microglial
apoptosis was demonstrated along disease progression, while the
macrophages derived from Ly6Chi monocytes proliferated in the
spinal cord parenchyma and
were associated with motor neuron loss (Butovsky et al., 2012).
Notably, in this study, resident microglia were compared only to
the inﬂammatory Ly6Chi mo-MΦ population, whereas a recent
study reported the recruitment of two blood-derived macrophage
populations following spinal cord injury: the Ly6ChiCX3CR1low
pro-inﬂammatory and Ly6ClowCX3CR1hi anti-inﬂammatory
cells, which acquire their phenotype via their trafﬁcking route
(Shechter et al., 2013). Thus, it will be interesting to characterize
the gene signature of both Ly6Chi and Ly6Clow mo-MΦ compared
to resident microglia, and also to address the issue of where, how
and when microglia acquire their phenotype.
All together, the evidence collected above indicates that under
extensive inﬂammatory conditions, microglia lose their beneﬁcial
functions and instead display a deleterious role, further con-
tributing to the spread of damage. Withstanding this vicious
inﬂammatory cycle requires the recruitment of mo-MΦ, which
induce resolution of the local immune response, rather than sim-
ply acting as microglial reinforcements. This perception leads,
however, to the question of what drives the functional disparity
between resident microglia and mo-MΦ. Speciﬁcally, what pre-
vents microglia from acquiring the essential immune-resolving
“alternatively activated” phenotype that is provided by the mo-
MΦ? The answers to these questions may lie in the distinct
origin of the two myeloid populations; microglial progenitors are
yolk sac-derived macrophages that inﬁltrate the CNS during early
embryogenesis, when bone marrow-derived hematopoiesis, from
which mo-MΦ originate, is not yet established (Ginhoux et al.,
2010; Schulz et al., 2012; Gomez Perdiguero et al., 2013). Educated
in the CNS from early ontogeny, microglia were never exposed
to any other environment; they have a relatively long life-span
and undergo moderate and limited turn-over by self-renewal of
primitive myeloid precursors (Ajami et al., 2007; Ginhoux et al.,
2010; Schulz et al., 2012; Gomez Perdiguero et al., 2013). In con-
trast, mo-MΦ are freshly recruited from the circulation. Their
differences may also be related to the fact that microglia are the
ﬁrst to encounter the damaged tissue, which might dictate their
phenotype, while the mo-MΦ, recruited at a slightly later stage,
acquire their nature via their trafﬁcking route to theCNS (Shechter
et al., 2013). Interestingly, such timely recruitment of myeloid
subsets with differential functions is also evident in insults of non-
CNS organs (Arnold et al., 2007; Nahrendorf et al., 2007). Clearly,
further research is needed in order to address these issues.
FUNCTIONAL RELATIONSHIPS BETWEEN THE MICROGLIA
AND mo-Mφ – A CASCADE OF EVENTS
Based on the data reviewed above, we suggest here a cascade of
events representing microglial functions within the CNS and the
distinct contribution of mo-MΦ. Microglia enter the CNS during
early developmental stages. By continuous scanning and sampling
their environment via their dynamic processes, microglia are able
to maintain CNS homeostasis; they preserve and modify (upon
need) the synapse complex, support neurogenesis, secrete essen-
tial growth factors, and sustain normal CNS performance. Once
encountering an unbalanced milieu, microglia become fully acti-
vated; retract their long ramiﬁcations, proliferate and shift toward
a “ready to act” mode. Their subsequent function is very much
dependent on their activation signal. A short and moderate stimu-
lus will direct microglia to rapidly eliminate the source of damage
without evoking a further immune response. Such stimuli are
part of routine CNS maintenance and are generally resolved with-
out activating or affecting other systems in the body. Even when
the stimulus is stronger but short-lived, microglia can potentially
cope with the danger signal, performing clearance of neurotoxic
factors, supporting regeneration, and secreting neurotrophic fac-
tors supportive of remyelination. However, when the stimulus is
intense or chronic, microglia can no longer handle the ongoing
damage; these cells become neurotoxic and release reactive oxy-
gen species, NO, proteases and pro-inﬂammatory cytokines, all
of which endanger neuronal activity. Such microglial malfunc-
tion results in signals for recruitment of mo-MΦ to the damage
site, which provide functions that cannot be delivered by the
resident cells; mo-MΦ restrict the local inﬂammation, attenu-
ate accumulation of misfolded proteins or any other intruders,
restore homeostasis, and support healing and renewal. Unfortu-
nately, the spontaneous response of mo-MΦ is often insufﬁcient
to achieve complete recovery. Thus, several therapeutic attempts
to boost such a protective response by either direct administra-
tion of monocytes or indirectly augmenting their recruitment are
currently underway (Figure 1).
LESSONS FROM OTHER TISSUE-SPECIFIC RESIDENT
MACROPHAGES
Although unique, microglia are not the sole tissue-speciﬁc
resident myeloid-derived cells. Many organs in the body contain
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FIGURE 1 | microglial and mo-MΦ functions – cascade of events.
(a) Resident microglia originate from yolk sac macrophages that repopulate
CNS parenchyma during early development and are self-renewed locally,
independent from bone marrow-derived monocytes, by proliferation of
primitive progenitors. (b) In the steady state microglia are constantly scanning
their environment through their highly motile processes. These
cells facilitate the maintenance of synapses (c) and neurogenesis (d),
as well as secrete growth factors essential for normal CNS performance
(e). Upon recognition of a danger signal, microglia retract their branches,
become round and ameboid, and convert into an activated mode (f). A
short or moderate signal directs microglia toward a neuroprotective
phenotype; these cells clear debris by phagocytosis (g), secrete growth
factors associated with remyelination (h) and support regeneration (i).
Intensive acute or chronic activation renders microglia neurotoxic; under such
conditions microglia fail to acquire a neuroprotective phenotype. Instead,
these cells produce reactive oxygen species (ROS), nitric oxide (NO),
proteases, and pro-inﬂammatory cytokines such as IL-1, IL-6, andTNF-α, all of
which endanger neuronal activity (j). Microglial malfunction results in the
recruitment of mo-MΦ to the damage site (k). mo-MΦ secrete
anti-inﬂammatory cytokines such as IL-10 andTGF-β, express factors
associated with immune resolution such as manose receptor and arginase 1
(ARG1), and promote neuroprotection and cell renewal (l), all of which are
functions that cannot be provided, under these conditions, by the resident
microglia.
FIGURE 2 | Lessons from other tissue-specific resident macrophages. (A)
Langerhans cells (LCs), the resident myeloid cells of the epidermis share with
microglia their scanning capacity, their activation mode and possibly, their
embryonic origin. Different from microglia these cells migrate to the lymph
node where they act as antigen presenting cells. (B) Analogous to microglia,
intestinal macrophages act as the ﬁrst line of defense, protecting the mucosa
from harmful pathogens and removing dead cells and debris. Unlike most
other tissue macrophages, upon activation by certain stimuli, these cells
produce immune-resolving factors. Distinct from microglia, circulating
monocytes are largely accepted as the source of intestinal macrophages,
however, the possibility of local self-renewal by embryonic precursors, under
steady state, was also raised. (C) Kupffer cells are the macrophages of the
liver. Similar to microglia, these cells perform clearance of host-related debris
and pathogens. Kupffer cells are classical antigen presenting cells; however
can also display immune-resolving functions. Moreover, they are largely
assumed to be self-renewed independently from circulating monocytes, but a
certain Kupffer cell subset was reported to originate from hematogenous
precursors.
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distinctive resident macrophages whose properties are tailored to
the host tissue (Figure 2). Langerhans cells (LCs), for example, are
the resident myeloid cells of the epidermis. Similar to microglia,
they have extended dendritic processes that embrace neighboring
keratinocytes (Langerhans, 1868; Bilzer et al., 2006) and scan the
epidermis for pathogens and toxic molecules (de Jong and Gei-
jtenbeek, 2010). These cells are endowed with the C-type lectin,
Langerin, used for interaction with bacteria, fungi, and viruses
(Turville et al., 2002; de Witte et al., 2007; Merad et al., 2008; de
Jong and Geijtenbeek, 2010). Like microglia, LCs descend from
embryonic precursors, possibly yolk sac macrophages or fetal
liver monocytes, and are renewed independently of the bone
marrow, by in situ proliferation upon need (Merad et al., 2002,
2008; Chorro et al., 2009; Chorro and Geissmann, 2010; Hoeffel
et al., 2012). Moreover, as in microglial activation, upon cap-
ture of pathogens, LCs undergo phenotypic changes including
increased expression of MHC-I and -II, and of the co-stimulatory
molecules CD80, CD86, and CD40 (Merad et al., 2008; de Jong
and Geijtenbeek, 2010). However, unlike microglia, which are
restricted to the CNS parenchyma, LCs upregulate the lymph
node-homing receptor, CCR7, which eventually leads to their
migration to peripheral lymph nodes where they induce a spe-
ciﬁc adaptive immune response against skin invading pathogens
(Merad et al., 2008). Intestinal macrophages are the largest popu-
lation of mononuclear phagocytes in the body (Smith et al., 2005;
Varol et al., 2010; Mowat and Bain, 2011). Similar to microglia,
they have essential functions under both normal and pathological
conditions; intestinal macrophages preserve a delicate equilib-
rium between commensal bacteria and the host, maintaining
epithelial integrity and mucosal homeostasis. These cells act as
the ﬁrst line of defense protecting the highly exposed mucosa
from harmful pathogens, removing dead cells and debris, and
modulating the local inﬂammatory response (Smith et al., 2005;
Varol et al., 2010; Mowat and Bain, 2011). Unlike other tissue
macrophages, upon activation, for instance by certain Toll-like
receptor (TLR) ligands, intestinal macrophages do not express
high levels of co-stimulatory molecules nor do they secrete
pro-inﬂammatory cytokines (Rogler et al., 1998; Hirotani et al.,
2005; Uematsu et al., 2006; Mowat and Bain, 2011; Smith et al.,
2011). Rather, they produce anti-inﬂammatory mediators such
as IL-10 and prostaglandin E2 that restrict the local immune
response (Mowat and Bain, 2011). Unlike microglia, the replen-
ishment of intestinal macrophages is mostly associated with the
recruitment of circulating monocytes. However, the possibility
of self-renewal under steady state has also been raised (Mowat
and Bain, 2011). Kupffer cells are the macrophages of the liver.
These cells are mainly involved in clearance of pathogens and
host-derived waste; they are constantly exposed to bacterial
endotoxin (LPS) and microbial debris delivered from the gastroin-
testinal tract (Naito et al., 2004) and are involved in removal of
senescent or malformed red blood cells and phagocytosis of sol-
uble immunoglobulin G (IgG) complexes, microorganisms and
eukaryotic cells (Naito et al., 2004; Parker and Picut, 2012). In
addition to their role as phagocytes, Kupffer cells act as effec-
tive antigen presenting cells; upon Hepatitis C virus infection,
human Kupffer cells elevate MHC-I and -II expression, upregu-
late co-stimulatory molecules, and interact with T cells (Burgio
et al., 1998). However, several studies also demonstrated the
immune-resolving nature of Kupffer cells, which were shown to
suppress lymphocytes in culture (Callery et al., 1991), secrete IL-10
in response to LPS challenge (Knolle et al., 1995) and facilitate
Fas ligand (FasL)-mediated apoptosis of T cells in a liver trans-
plant model (Miyagawa-Hayashino et al., 2007). Thus, similarly
to CNS heterogeneous macrophages, Kupffer cells seem to per-
form highly versatile functions. These cells, like microglia and
LCs appear to self-renew independently of bone marrow-derived
precursors (Schulz et al., 2012; Gomez Perdiguero et al., 2013).
However, a study addressing Kupffer cell heterogeneity identi-
ﬁed two subsets of Kupffer cells; one of them is radiosensitive
and rapidly replaced from hematogenous precursors (Klein et al.,
2007), indicating that the issue of Kupffer cell renewal is still
unresolved.
CONCLUSIONS AND FUTURE DIRECTIONS
The evidence collected in this perspective supports the concept of
functionalmacrophage heterogeneitywithin theCNS.Due to their
similar morphology, previously assumed shared origin and sub-
sequent misleading nomenclature, as well as the lack of available
techniques to distinguish between the two populations, microglia
and mo-MΦ were erroneously assumed to comprise a single pop-
ulation. Alternatively, and based on the ample ﬁndings addressed
above, ourmodel suggests thatwhen it comes toCNSmacrophages
initial impressions can be deceiving; although they appear similar,
mo-MΦ and microglia present different gene expression patterns
and phenotypes, and are functionally distinct. Additional research
is needed in order to further reveal the different function of these
two distinct populations and the conditions that determine their
unique phenotype. Such research will help resolving the misun-
derstanding that resulted from the previously held blanket view
of these cells as homogeneously destructive, and might assist in
employing speciﬁc manipulations of the two subsets as a potential
therapeutic approach.
REFERENCES
Aarum, J., Sandberg, K., Haeberlein,
S. L., and Persson, M. A. (2003).
Migration and differentiation of neu-
ral precursor cells can be directed
by microglia. Proc. Natl. Acad. Sci.
U.S.A. 100, 15983–15988.
Ajami, B., Bennett, J. L., Krieger, C.,
Mcnagny, K. M., and Rossi, F. M.
(2011). Inﬁltrating monocytes trig-
ger EAE progression, but do not
contribute to the resident microglia
pool. Nat. Neurosci. 14, 1142–
1149.
Ajami, B., Bennett, J. L., Krieger, C.,
Tetzlaff, W., and Rossi, F. M. (2007).
Local self-renewal can sustain CNS
microglia maintenance and function
throughout adult life. Nat. Neurosci.
10, 1538–1543.
Arnold, L., Henry, A., Poron, F.,
Baba-Amer, Y., Van Rooijen, N.,
Plonquet, A., et al. (2007). Inﬂam-
matory monocytes recruited after
skeletal muscle injury switch into
antiinﬂammatory macrophages to
supportmyogenesis. J. Exp. Med. 204,
1057–1069.
Auffray, C., Sieweke, M. H., and
Geissmann, F. (2009). Blood mono-
cytes: development, heterogene-
ity, and relationship with dendritic
cells. Annu. Rev. Immunol. 27,
669–692.
Avidan, H., Kipnis, J., Butovsky, O.,
Caspi, R. R., and Schwartz,M. (2004).
Vaccination with autoantigen pro-
tects against aggregated beta-amyloid
and glutamate toxicity by controlling
microglia: effect of CD4+CD25+ T
cells. Eur. J. Immunol. 34, 3434–3445.
Batchelor, P. E., Liberatore, G. T.,
Wong, J. Y., Porritt, M. J., Frerichs,
F., Donnan, G. A., et al. (1999).
Activatedmacrophages andmicroglia
induce dopaminergic sprouting in
the injured striatum and express
brain-derived neurotrophic factor
Frontiers in Cellular Neuroscience www.frontiersin.org April 2013 | Volume 7 | Article 34 | 6
“fncel-07-00034” — 2013/4/5 — 13:16 — page 7 — #7
London et al. Macrophage heterogeneity within the CNS
and glial cell line-derived neu-
rotrophic factor. J. Neurosci. 19,
1708–1716.
Bechmann, I., Goldmann, J., Kovac,
A. D., Kwidzinski, E., Simburger, E.,
Naftolin, F., et al. (2005). Circulat-
ing monocytic cells inﬁltrate layers
of anterograde axonal degeneration
where they transform into microglia.
FASEB J. 19, 647–649.
Beers, D. R., Henkel, J. S., Xiao, Q.,
Zhao, W., Wang, J., Yen, A. A., et al.
(2006). Wild-type microglia extend
survival in PU.1 knockout mice with
familial amyotrophic lateral sclero-
sis. Proc. Natl. Acad. Sci. U.S.A. 103,
16021–16026.
Bilzer, M., Roggel, F., and Gerbes, A. L.
(2006). Role of Kupffer cells in host
defense and liver disease. Liver Int. 26,
1175–1186.
Block, M. L., and Hong, J. S. (2005).
Microglia and inﬂammation-media-
ted neurodegeneration:multiple trig-
gers with a common mechanism.
Prog. Neurobiol. 76, 77–98.
Block, M. L., Zecca, L., and Hong, J.
S. (2007). Microglia-mediated neu-
rotoxicity: uncovering the molecular
mechanisms. Nat. Rev. Neurosci. 8,
57–69.
Boillée, S., Yamanaka, K., Lobsiger, C.
S., Copeland, N. G., Jenkins, N. A.,
Kassiotis, G., et al. (2006). Onset
and progression in inherited ALS
determined by motor neurons and
microglia. Science 2, 1389–1392.
Boster, A., Edan, G., Frohman, E.,
Javed, A., Stuve, O., Tselis, A., et al.
(2008). Intense immunosuppression
in patients with rapidly worsening
multiple sclerosis: treatment guide-
lines for the clinician. Lancet Neurol.
7, 173–183.
Burgio, V. L., Ballardini, G., Artini, M.,
Caratozzolo, M., Bianchi, F. B., and
Levrero, M. (1998). Expression of
co-stimulatory molecules by Kupffer
cells in chronic hepatitis of hepati-
tis C virus etiology. Hepatology 27,
1600–1606.
Butovsky, O., Hauben, E., and Schwartz,
M. (2001). Morphological aspects of
spinal cord autoimmune neuropro-
tection: colocalization of T cells with
B7–2 (CD86) and prevention of cyst
formation. FASEB J. 15, 1065–1067.
Butovsky, O., Koronyo-Hamaoui, M.,
Kunis, G., Ophir, E., Landa,
G., Cohen, H., et al. (2006a).
Glatiramer acetate ﬁghts against
Alzheimer’s disease by inducing
dendritic-like microglia expressing
insulin-like growth factor 1. Proc.
Natl. Acad. Sci. U.S.A. 103, 11784–
11789.
Butovsky, O., Landa, G., Kunis, G.,
Ziv, Y., Avidan, H., Greenberg, N.,
et al. (2006b). Induction and block-
age of oligodendrogenesis by differ-
ently activatedmicroglia in an animal
model of multiple sclerosis. J. Clin.
Invest. 116, 905–915.
Butovsky, O., Ziv, Y., Schwartz,
A., Landa, G., Talpalar, A. E.,
Pluchino, S., et al. (2006c). Microglia
activated by IL-4 or IFN-gamma
differentially induce neurogenesis
and oligodendrogenesis from adult
stem/progenitor cells. Mol. Cell. Neu-
rosci. 31, 149–160.
Butovsky, O., Kunis, G., Koronyo-
Hamaoui, M., and Schwartz, M.
(2007). Selective ablation of bone
marrow-derived dendritic cells
increases amyloid plaques in a mouse
Alzheimer’s disease model. Eur. J.
Neurosci. 26, 413–416.
Butovsky, O., Siddiqui, S., Gabriely, G.,
Lanser, A. J., Dake, B., Murugaiyan,
G., et al. (2012). Modulating inﬂam-
matory monocytes with a unique
microRNA gene signature amelio-
rates murine ALS. J. Clin. Invest. 122,
3063–3087.
Butovsky, O., Talpalar, A. E., Ben-
Yaakov, K., and Schwartz, M. (2005).
Activation of microglia by aggre-
gated beta-amyloid or lipopolysac-
charide impairs MHC-II expression
and renders them cytotoxic whereas
IFN-gamma and IL-4 render them
protective. Mol. Cell. Neurosci. 29,
381–393.
Cajal, S. R. (1913). Contribución al
conocimiento de la neuroglia del
cerebro humano. Trab. Lab. Invest.
Biol. 11, 255–345.
Callery, M. P., Mangino, M. J., and
Flye, M. W. (1991). Arginine-speciﬁc
suppression of mixed lymphocyte
culture reactivity by Kupffer cells –
a basis of portal venous tolerance.
Transplantation 51, 1076–1080.
Carson, M. J., Bilousova, T. V., Puntam-
bekar, S. S., Melchior, B., Doose, J.
M., and Ethell, I. M. (2007). A rose by
any other name? The potential con-
sequences of microglial heterogene-
ity during CNS health and disease.
Neurotherapeutics 4, 571–579.
Centonze, D., Muzio, L., Rossi, S.,
Cavasinni, F., De Chiara, V., Bergami,
A., et al. (2009). Inﬂammation trig-
gers synaptic alteration and degen-
eration in experimental autoimmune
encephalomyelitis. J. Neurosci. 29,
3442–3452.
Choi, S. H.,Veeraraghavalu, K., Lazarov,
O., Marler, S., Ransohoff, R. M.,
Ramirez, J. M., et al. (2008). Non-
cell-autonomous effects of presenilin
1 variants on enrichment-mediated
hippocampal progenitor cell prolifer-
ation and differentiation. Neuron 59,
568–580.
Chorro, L., and Geissmann, F. (2010).
Development and homeostasis of
‘resident’myeloid cells: the case of the
Langerhans cell. Trends Immunol. 31,
438–445.
Chorro, L., Sarde, A., Li, M., Wool-
lard, K. J., Chambon, P., Malissen,
B., et al. (2009). Langerhans cell
(LC) proliferation mediates neona-
tal development, homeostasis, and
inﬂammation-associated expansion
of the epidermal LC network. J. Exp.
Med. 206, 3089–3100.
Chung, H., Brazil, M. I., Soe, T. T., and
Maxﬁeld, F. R. (1999). Uptake, degra-
dation, and release of ﬁbrillar and
soluble forms of Alzheimer’s amy-
loid beta-peptide by microglial cells.
J. Biol. Chem. 274, 32301–32308.
Colton, C. A. (2013). Immune het-
erogeneity in neuroinﬂammation:
dendritic cells in the brain. J. Neu-
roimmune Pharmacol. 8, 145–162.
Davalos, D., Grutzendler, J., Yang,
G., Kim, J. V., Zuo, Y., Jung, S.,
et al. (2005). ATP mediates rapid
microglial response to local brain
injury in vivo. Nat. Neurosci. 8,
752–758.
de Jong, M. A., and Geijtenbeek, T.
B. (2010). Langerhans cells in innate
defense against pathogens. Trends
Immunol. 31, 452–459.
Del Rio-Hortega, P. (1919). El tercer
elemento de los centros nerviosos
I La microglia en estado normal II
Intervencíon de la microglia en los
procesos patológicos III Naturaleza
probable de la microglia. Bol. de la
Soc. Esp. de Biol. 9, 69–120.
Derecki, N. C., Cronk, J. C., and Kip-
nis, J. (2013). The role of microglia in
brain maintenance: implications for
Rett syndrome. Trends Immunol. 34,
144–150.
Derecki, N. C., Cronk, J. C., Lu,
Z., Xu, E., Abbott, S. B., Guyenet,
P. G., et al. (2012). Wild-type
microglia arrest pathology in amouse
model of Rett syndrome. Nature 484,
105–109.
de Witte, L., Nabatov, A., Pion, M.,
Fluitsma, D., De Jong, M. A., De
Gruijl, T., et al. (2007). Langerin is
a natural barrier to HIV-1 transmis-
sion by Langerhans cells. Nat. Med.
13, 367–371.
Eglitis, M. A., and Mezey, E. (1997).
Hematopoietic cells differentiate into
both microglia and macroglia in the
brains of adult mice. Proc. Natl. Acad.
Sci. U.S.A. 94, 4080–4085.
Ekdahl, C. T., Claasen, J. H., Bonde,
S., Kokaia, Z., and Lindvall, O.
(2003). Inﬂammation is detrimental
for neurogenesis in adult brain. Proc.
Natl. Acad. Sci. U.S.A. 100, 13632–
13637.
Elkabes, S., Dicicco-Bloom, E. M.,
and Black, I. B. (1996). Brain
microglia/macrophages express neu-
rotrophins that selectively regulate
microglial proliferation and func-
tion. J. Neurosci. 16, 2508–
2521.
Ginhoux, F., Greter, M., Leboeuf, M.,
Nandi, S., See, P., Gokhan, S.,
et al. (2010). Fate mapping analy-
sis reveals that adult microglia derive
from primitive macrophages. Science
330, 841–845.
Gomez Perdiguero, E., Schulz, C.,
and Geissmann, F. (2013). Devel-
opment and homeostasis of “resi-
dent” myeloid cells: the case of the
microglia. Glia 61, 112–120.
Gordon, S. (2003). Alternative acti-
vation of macrophages. Nat. Rev.
Immunol. 3, 23–35.
Gordon, S., and Martinez, F. O.
(2010). Alternative activation of
macrophages: mechanism and func-
tions. Immunity 32, 593–604.
Gordon, S., and Taylor, P. R. (2005).
Monocyte and macrophage hetero-
geneity. Nat. Rev. Immunol. 5,
953–964.
Gris, D., Marsh, D. R., Oatway, M.
A., Chen, Y., Hamilton, E. F., Dek-
aban, G. A., et al. (2004). Tran-
sient blockade of the CD11d/CD18
integrin reduces secondary damage
after spinal cord injury, improv-
ing sensory, autonomic, and motor
function. J. Neurosci. 24, 4043–
4051.
Hanisch, U. K., and Kettenmann, H.
(2007). Microglia: active sensor and
versatile effector cells in the normal
and pathologic brain. Nat. Neurosci.
10, 1387–1394.
Hausler, K. G., Prinz, M., Nolte, C.,
Weber, J. R., Schumann,R. R., Ketten-
mann, H., et al. (2002). Interferon-
gamma differentially modulates the
release of cytokines and chemokines
in lipopolysaccharide- and pneumo-
coccal cell wall-stimulated mouse
microglia and macrophages. Eur. J.
Neurosci. 16, 2113–2122.
Heppner, F. L., Greter, M., Marino, D.,
Falsig, J., Raivich, G., Hovelmeyer, N.,
et al. (2005). Experimental autoim-
mune encephalomyelitis repressed by
microglial paralysis. Nat. Med. 11,
146–152.
Hirasawa, T., Ohsawa, K., Imai, Y.,
Ondo, Y., Akazawa, C., Uchino,
S., et al. (2005). Visualization of
microglia in living tissues using Iba1-
EGFP transgenic mice. J. Neurosci.
Res. 81, 357–362.
Hirotani, T., Lee, P. Y., Kuwata,
H., Yamamoto, M., Matsumoto,
M., Kawase, I., et al. (2005).
The nuclear IkappaB protein
Frontiers in Cellular Neuroscience www.frontiersin.org April 2013 | Volume 7 | Article 34 | 7
“fncel-07-00034” — 2013/4/5 — 13:16 — page 8 — #8
London et al. Macrophage heterogeneity within the CNS
IkappaBNS selectively inhibits
lipopolysaccharide-induced IL-6
production in macrophages of the
colonic lamina propria. J. Immunol.
174, 3650–3657.
Hoeffel, G., Wang, Y., Greter, M.,
See, P., Teo, P., Malleret, B.,
et al. (2012). Adult Langerhans cells
derive predominantly from embry-
onic fetal liver monocytes with a
minor contribution of yolk sac-
derived macrophages. J. Exp. Med.
209, 1167–1181.
Hsieh, J., Aimone, J. B., Kaspar, B. K.,
Kuwabara, T., Nakashima, K., and
Gage, F. H. (2004). IGF-I instructs
multipotent adult neural progenitor
cells to become oligodendrocytes. J.
Cell Biol. 164, 111–122.
Jung, S., Aliberti, J., Graemmel, P.,
Sunshine, M. J., Kreutzberg, G.
W., Sher, A., et al. (2000). Analy-
sis of fractalkine receptor CX(3)CR1
function by targeted deletion and
green ﬂuorescent protein reporter
gene insertion. Mol. Cell. Biol. 20,
4106–4114.
Kettenmann, H., Hanisch, U. K., Noda,
M., andVerkhratsky, A. (2011). Phys-
iology of microglia. Physiol. Rev. 91,
461–553.
Klein, I., Cornejo, J. C., Polakos, N. K.,
John, B., Wuensch, S. A., Topham,
D. J., et al. (2007). Kupffer cell het-
erogeneity: functional properties of
bonemarrow derived and sessile hep-
atic macrophages. Blood 110, 4077–
4085.
Knolle, P., Schlaak, J., Uhrig, A., Kempf,
P., Meyer Zum Buschenfelde, K. H.,
andGerken,G. (1995). HumanKupf-
fer cells secrete IL-10 in response to
lipopolysaccharide (LPS) challenge.
J. Hepatol. 22, 226–229.
Kotter, M. R., Setzu, A., Sim, F.
J., Van Rooijen, N., and Franklin,
R. J. (2001). Macrophage depletion
impairs oligodendrocyte remyelina-
tion following lysolecithin-induced
demyelination. Glia 35, 204–212.
Langerhans, P. (1868). Über die Ner-
ven der menschlichen Haut.Virchows
Arch. 44, 325–337.
Lee, J. L., Everitt, B. J., and Thomas,
K. L. (2004). Independent cellular
processes for hippocampal memory
consolidation and reconsolidation.
Science 304, 839–843.
Liu, Y., Hao, W., Letiembre, M., Wal-
ter, S., Kulanga, M., Neumann,
H., et al. (2006). Suppression of
microglial inﬂammatory activity by
myelin phagocytosis: role of p47-
PHOX-mediated generation of reac-
tive oxygen species. J. Neurosci. 26,
12904–12913.
London, A., Itskovich, E., Benhar, I.,
Kalchenko, V., Mack, M., Jung, S.,
et al. (2011). Neuroprotection and
progenitor cell renewal in the injured
adult murine retina requires heal-
ing monocyte-derived macrophages.
J. Exp. Med. 208, 23–39.
Maezawa, I., and Jin, L. W. (2010). Rett
syndrome microglia damage den-
drites and synapses by the elevated
release of glutamate. J. Neurosci. 30,
5346–5356.
Magnus, T., Chan,A., Grauer, O., Toyka,
K. V., and Gold, R. (2001). Microglial
phagocytosis of apoptotic inﬂamma-
tory T cells leads to down-regulation
of microglial immune activation. J.
Immunol. 167, 5004–5010.
Majumdar, A., Cruz, D., Asamoah, N.,
Buxbaum, A., Sohar, I., Lobel, P.,
et al. (2007). Activation of microglia
acidiﬁes lysosomes and leads to
degradation of Alzheimer amyloid
ﬁbrils. Mol. Biol. Cell 18, 1490–
1496.
Mantovani, A., Sica, A., and Locati,
M. (2005). Macrophage polarization
comes of age. Immunity 23, 344–346.
Martinez, F. O., Helming, L., and Gor-
don, S. (2009). Alternative activation
of macrophages: an immunologic
functional perspective. Annu. Rev.
Immunol. 27, 451–483.
McGeer, P. L.,McGeer, E., Rogers, J., and
Sibley, J. (1990). Anti-inﬂammatory
drugs and Alzheimer disease. Lancet
335, 1037.
McKercher, S. R., Torbett, B. E., Ander-
son, K. L., Henkel, G. W., Vestal, D.
J., Baribault, H., et al. (1996). Tar-
geted disruption of the PU.1 gene
results in multiple hematopoietic
abnormalities. EMBO J. 15, 5647–
5658.
Merad, M., Ginhoux, F., and Collin,
M. (2008). Origin, homeostasis
and function of Langerhans cells
and other langerin-expressing den-
dritic cells. Nat. Rev. Immunol. 8,
935–947.
Merad, M., Manz, M. G., Karsunky, H.,
Wagers, A., Peters, W., Charo, I., et al.
(2002). Langerhans cells renew in the
skin throughout life under steady-
state conditions. Nat. Immunol. 3,
1135–1141.
Mildner, A., Schlevogt, B., Kierdorf, K.,
Bottcher, C., Erny, D., Kummer, M.
P., et al. (2011). Distinct and non-
redundant roles of microglia and
myeloid subsets in mouse models of
Alzheimer’s disease. J. Neurosci. 31,
11159–11171.
Mildner, A., Schmidt, H., Nitsche,
M., Merkler, D., Hanisch, U. K.,
Mack, M., et al. (2007). Microglia
in the adult brain arise from Ly-
6ChiCCR2+ monocytes only under
deﬁned host conditions. Nat. Neu-
rosci. 10, 1544–1553.
Miyagawa-Hayashino, A., Tsuruyama,
T., Egawa,H.,Haga,H., Sakashita,H.,
Okuno, T., et al. (2007). FasL expres-
sion in hepatic antigen-presenting
cells and phagocytosis of apoptotic T
cells by FasL+ Kupffer cells are indi-
cators of rejection activity in human
liver allografts. Am. J. Pathol. 171,
1499–1508.
Mizuno, M., Yamada, K., Olariu,
A., Nawa, H., and Nabeshima, T.
(2000). Involvement of brain-derived
neurotrophic factor in spatial mem-
ory formation and maintenance in
a radial arm maze test in rats. J.
Neurosci. 20, 7116–7121.
Monje, M. L., Toda, H., and Palmer,
T. D. (2003). Inﬂammatory blockade
restores adult hippocampal neuroge-
nesis. Science 302, 1760–1765.
Mosser, D. M., and Edwards, J. P.
(2008). Exploring the full spectrum
of macrophage activation. Nat. Rev.
Immunol. 8, 958–969.
Mowat, A. M., and Bain, C. C. (2011).
Mucosal macrophages in intestinal
homeostasis and inﬂammation. J.
Innate Immun. 3, 550–564.
Munn, N. A. (2000). Microglia dys-
function in schizophrenia: an inte-
grative theory. Med. Hypotheses 54,
198–202.
Murabe, Y., and Sano, Y. (1982). Mor-
phological studies on neuroglia. V.
Microglial cells in the cerebral cortex
of the rat, with special reference to
their possible involvement in synap-
tic function. Cell Tissue Res. 223,
493–506.
Muzio, L., Martino, G., and Furlan,
R. (2007). Multifaceted aspects of
inﬂammation in multiple sclerosis:
the role of microglia. J. Neuroim-
munol. 191, 39–44.
Nahrendorf, M., Swirski, F. K., Aikawa,
E., Stangenberg, L., Wurdinger,
T., Figueiredo, J. L., et al. (2007).
The healing myocardium sequen-
tiallymobilizes twomonocyte subsets
with divergent and complementary
functions. J. Exp. Med. 204, 3037–
3047.
Naito, M., Hasegawa, G., Ebe, Y., and
Yamamoto, T. (2004). Differentiation
and function of Kupffer cells. Med.
Electron Microsc. 37, 16–28.
Nakajima, K., Honda, S., Tohyama, Y.,
Imai, Y., Kohsaka, S., and Kurihara, T.
(2001). Neurotrophin secretion from
cultured microglia. J. Neurosci. Res.
65, 322–331.
Neumann, J., Gunzer, M., Gutzeit, H.
O., Ullrich, O., Reymann, K. G., and
Dinkel, K. (2006). Microglia pro-
vide neuroprotection after ischemia.
FASEB J. 20, 714–716.
Neumann, J., Sauerzweig, S., Ronicke,
R., Gunzer, F., Dinkel, K., Ullrich,
O., et al. (2008). Microglia cells pro-
tect neurons by direct engulfment
of invading neutrophil granulocytes:
a new mechanism of CNS immune
privilege. J. Neurosci. 28, 5965–
5975.
Nimmerjahn, A., Kirchhoff, F., and
Helmchen, F. (2005). Resting
microglial cells are highly dynamic
surveillants of brain parenchyma
in vivo. Science 308, 1314–
1318.
Okamura, T., Katayama, T., Obinata,
C., Iso, Y., Chiba, Y., Kobayashi,
H., et al. (2012). Neuronal injury
induces microglial production of
macrophage inﬂammatory protein-
1alpha in rat corticostriatal slice
cultures. J. Neurosci. Res. 90, 2127–
2133.
Ovanesov, M. V., Moldovan, K., Smith,
K., Vogel, M. W., and Pletnikov,
M. V. (2008). Persistent Borna Dis-
ease Virus (BDV) infection activates
microglia prior to a detectable loss of
granule cells in the hippocampus. J.
Neuroinﬂammation 5, 16.
Paolicelli, R. C., Bolasco, G., Pagani, F.,
Maggi, L., Scianni, M., Panzanelli,
P., et al. (2011). Synaptic pruning
by microglia is necessary for nor-
mal brain development. Science 333,
1456–1458.
Parker, G. A., and Picut, C. A. (2012).
Immune functioning in non lym-
phoid organs: the liver. Toxicol.
Pathol. 40, 237–247.
Perry, V. H., Nicoll, J. A., and Holmes,
C. (2010). Microglia in neurodegen-
erative disease. Nat. Rev. Neurol. 6,
193–201.
Popovich, P. G., Guan, Z., Wei,
P., Huitinga, I., Van Rooijen, N.,
and Stokes, B. T. (1999). Depletion
of hematogenous macrophages pro-
motes partial hindlimb recovery and
neuroanatomical repair after experi-
mental spinal cord injury. Exp. Neu-
rol. 158, 351–365.
Popovich, P. G., and Hickey, W. F.
(2001). Bone marrow chimeric rats
reveal the unique distribution of
resident and recruited macrophages
in the contused rat spinal cord.
J. Neuropathol. Exp. Neurol. 60,
676–685.
Prewitt, C. M., Niesman, I. R., Kane, C.
J., and Houle, J. D. (1997). Activated
macrophage/microglial cells can pro-
mote the regeneration of sensory
axons into the injured spinal cord.
Exp. Neurol. 148, 433–443.
Priller, J., Flugel, A., Wehner, T.,
Boentert, M., Haas, C. A., Prinz,
M., et al. (2001). Targeting gene-
modiﬁed hematopoietic cells to the
central nervous system: use of
green ﬂuorescent protein uncovers
Frontiers in Cellular Neuroscience www.frontiersin.org April 2013 | Volume 7 | Article 34 | 8
“fncel-07-00034” — 2013/4/5 — 13:16 — page 9 — #9
London et al. Macrophage heterogeneity within the CNS
microglial engraftment. Nat. Med. 7,
1356–1361.
Prinz, M., Priller, J., Sisodia, S.
S., and Ransohoff, R. M. (2011).
Heterogeneity of CNS myeloid cells
and their roles in neurodegeneration.
Nat. Neurosci. 14, 1227–1235.
Rabchevsky, A. G., and Streit, W.
J. (1997). Grafting of cultured
microglial cells into the lesioned
spinal cord of adult rats enhances
neurite outgrowth. J. Neurosci. Res.
47, 34–48.
Ransohoff, R. M., and Engelhardt, B.
(2012). The anatomical and cellu-
lar basis of immune surveillance in
the central nervous system. Nat. Rev.
Immunol. 12, 623–635.
Ransohoff, R. M., and Perry, V.
H. (2009). Microglial physiology:
unique stimuli, specialized responses.
Annu. Rev. Immunol. 27, 119–145.
Ravichandran, K. S. (2003). “Recruit-
ment signals” from apoptotic cells:
invitation to a quiet meal. Cell 113,
817–820.
Rogler, G., Hausmann, M., Vogl, D.,
Aschenbrenner, E., Andus, T., Falk,
W., et al. (1998). Isolation and phe-
notypic characterization of colonic
macrophages. Clin. Exp. Immunol.
112, 205–215.
Rolls, A., Shechter, R., London,
A., Segev, Y., Jacob-Hirsch, J.,
Amariglio, N., et al. (2008). Two
faces of chondroitin sulfate proteo-
glycan in spinal cord repair: a role
in microglia/macrophage activation.
PLoS Med. 5:e171. doi: 10.1371/jour-
nal.pmed.0050171
Saederup, N., Cardona, A. E., Croft,
K., Mizutani, M., Cotleur, A. C.,
Tsou, C. L., et al. (2010). Selective
chemokine receptor usage by cen-
tral nervous system myeloid cells in
CCR2-red ﬂuorescent protein knock-
in mice. PLoS ONE 5:e13693. doi:
10.1371/journal.pone.0013693
Sargsyan, S. A., Blackburn, D. J., Bar-
ber, S. C., Monk, P. N., and Shaw,
P. J. (2009). Mutant SOD1 G93A
microglia have an inﬂammatory phe-
notype and elevated production of
MCP-1. Neuroreport 20, 1450–
1455.
Scheffel, J., Regen, T., Van Rossum, D.,
Seifert, S., Ribes, S., Nau, R., et al.
(2012). Toll-like receptor activation
reveals developmental reorganization
and unmasks responder subsets of
microglia. Glia 60, 1930–1943.
Schulz, C., Gomez Perdiguero, E.,
Chorro, L., Szabo-Rogers, H.,
Cagnard, N., Kierdorf, K., et al.
(2012). A lineage of myeloid
cells independent of Myb and
hematopoietic stem cells. Science 336,
86–90.
Schwartz, M., Butovsky, O., Bruck,
W., and Hanisch, U. K. (2006).
Microglial phenotype: is the commit-
ment reversible? Trends Neurosci. 29,
68–74.
Shaked, I., Porat, Z., Gersner, R., Kip-
nis, J., and Schwartz, M. (2004).
Early activation of microglia as
antigen-presenting cells correlates
with T cell-mediated protection and
repair of the injured central ner-
vous system. J. Neuroimmunol. 146,
84–93.
Shaked, I., Tchoresh, D., Gersner,
R., Meiri, G., Mordechai, S., Xiao,
X., et al. (2005). Protective autoim-
munity: interferon-gamma enables
microglia to remove glutamate with-
out evoking inﬂammatorymediators.
J. Neurochem. 92, 997–1009.
Shechter, R., London, A., Varol,
C., Raposo, C., Cusimano, M.,
Yovel, G., et al. (2009). Inﬁltrating
blood-derived macrophages are vital
cells playing an anti-inﬂammatory
role in recovery from spinal cord inj-
ury in mice. PLoS Med. 6:e1000113.
doi: 10.1371/journal.pmed.1000113
Shechter, R.,Miller,O.,Yovel, G., Rosen-
zweig, N., London, A., Ruckh, J.,
et al. (2013). Recruitment of ben-
eﬁcial M2 macrophages to injured
spinal cord is orchestrated by remote
brain choroid plexus. Immunity
doi: 10.1016/j.immuni.2013.02.012
[Epub ahead of print].
Shechter, R., Raposo, C., London, A.,
Sagi, I., and Schwartz, M. (2011).
The glial scar-monocyte interplay:
a pivotal resolution phase in spinal
cord repair. PLoS ONE 6:e27969. doi:
10.1371/journal.pone.0027969
Sica, A., and Mantovani, A. (2012).
Macrophage plasticity and polariza-
tion: in vivo veritas. J. Clin. Invest.
122, 787–795.
Sierra, A., Encinas, J. M., Deudero,
J. J., Chancey, J. H., Enikolopov,
G., Overstreet-Wadiche, L. S.,
et al. (2010). Microglia shape adult
hippocampal neurogenesis through
apoptosis-coupled phagocytosis. Cell
Stem Cell 7, 483–495.
Simard, A. R., Soulet, D., Gowing, G.,
Julien, J. P., and Rivest, S. (2006).
Bone marrow-derived microglia play
a critical role in restricting senile
plaque formation in Alzheimer’s dis-
ease. Neuron 49, 489–502.
Smith, P. D., Ochsenbauer-Jambor, C.,
and Smythies, L. E. (2005). Intestinal
macrophages: unique effector cells of
the innate immune system. Immunol.
Rev. 206, 149–159.
Smith, P. D., Smythies, L. E., Shen,
R., Greenwell-Wild, T., Gliozzi, M.,
and Wahl, S. M. (2011). Intesti-
nal macrophages and response to
microbial encroachment. Mucosal
Immunol. 4, 31–42.
Stadelmann, C., Kerschensteiner, M.,
Misgeld, T., Bruck, W., Hohlfeld, R.,
and Lassmann, H. (2002). BDNF and
gp145trkB in multiple sclerosis brain
lesions: neuroprotective interactions
between immune and neuronal cells?
Brain 125, 75–85.
Stalder, M., Deller, T., Staufenbiel,
M., and Jucker, M. (2001). 3D-
Reconstruction of microglia and
amyloid in APP23 transgenic
mice: no evidence of intracellu-
lar amyloid. Neurobiol. Aging 22,
427–434.
Stirling, D. P., Khodarahmi, K., Liu,
J., Mcphail, L. T., Mcbride, C. B.,
Steeves, J. D., et al. (2004). Minocy-
cline treatment reduces delayed
oligodendrocyte death, attenu-
ates axonal dieback, and improves
functional outcome after spinal
cord injury. J. Neurosci. 24, 2182–
2190.
Streit, W. J. (2002). Microglia as neuro-
protective, immunocompetent cells
of the CNS. Glia 40, 133–139.
Thored, P., Heldmann, U., Gomes-Leal,
W., Gisler, R., Darsalia, V., Taneera,
J., et al. (2009). Long-term accumu-
lation of microglia with proneuro-
genic phenotype concomitant with
persistent neurogenesis in adult sub-
ventricular zone after stroke. Glia 57,
835–849.
Tremblay, M. E. (2011). The role of
microglia at synapses in the healthy
CNS: novel insights from recent
imaging studies. Neuron Glia Biol. 7,
67–76.
Turville, S. G., Cameron, P. U., Han-
dley, A., Lin, G., Pohlmann, S.,
Doms, R. W., et al. (2002). Diversity
of receptors binding HIV on den-
dritic cell subsets. Nat. Immunol. 3,
975–983.
Uematsu, S., Jang, M. H., Chevrier, N.,
Guo, Z., Kumagai, Y., Yamamoto, M.,
et al. (2006). Detection of pathogenic
intestinal bacteria by Toll-like recep-
tor 5 on intestinal CD11c+ lam-
ina propria cells. Nat. Immunol. 7,
868–874.
Varol, C., Zigmond, E., and Jung,
S. (2010). Securing the immune
tightrope: mononuclear phago-
cytes in the intestinal lamina
propria. Nat. Rev. Immunol. 10,
415–426.
Vukovic, J., Colditz, M. J., Blackmore,
D. G., Ruitenberg, M. J., and Bartlett,
P. F. (2012). Microglia modulate hip-
pocampal neural precursor activity
in response to exercise and aging. J.
Neurosci. 32, 6435–6443.
Wake, H., Moorhouse, A. J., Jinno, S.,
Kohsaka, S., and Nabekura, J. (2009).
Resting microglia directly monitor
the functional state of synapses in
vivo and determine the fate of
ischemic terminals. J. Neurosci. 29,
3974–3980.
Walton, N. M., Sutter, B. M., Laywell, E.
D., Levkoff, L. H., Kearns, S. M., Mar-
shall, G. P. II, et al. (2006). Microglia
instruct subventricular zone neuro-
genesis. Glia 54, 815–825.
Wang, Y., Zhang, T. Y., Xin, J., Li, T.,
Yu, H., Li, N., et al. (2012). Differ-
ential involvement of brain-derived
neurotrophic factor in reconsolida-
tion and consolidation of condi-
tioned taste aversion memory. PLoS
ONE 7:e49942. doi: 10.1371/jour-
nal.pone.0049942
Wegiel, J., Wang, K. C., Imaki, H.,
Rubenstein, R., Wronska, A., Osu-
chowski, M., et al. (2001). The role of
microglial cells and astrocytes in ﬁb-
rillar plaque evolution in transgenic
APP(SW) mice. Neurobiol. Aging 22,
49–61.
Wilson, E. H., Weninger, W., and
Hunter, C. A. (2010). Trafﬁcking
of immune cells in the central ner-
vous system. J. Clin. Invest. 120,
1368–1379.
Wolf, S. A., Steiner, B., Akpinarli,
A., Kammertoens, T., Nassenstein,
C., Braun, A., et al. (2009). CD4-
positive T lymphocytes provide a
neuroimmunological link in the
control of adult hippocampal neu-
rogenesis. J. Immunol. 182, 3979–
3984.
Wright, D. E., Wagers, A. J., Gulati,
A. P., Johnson, F. L., and Weiss-
man, I. L. (2001). Physiological
migration of hematopoietic stem and
progenitor cells. Science 294, 1933–
1936.
Yin, Y., Henzl, M. T., Lorber, B.,
Nakazawa, T., Thomas, T. T., Jiang,
F., et al. (2006). Oncomodulin is a
macrophage-derived signal for axon
regeneration in retinal ganglion cells.
Nat. Neurosci. 9, 843–852.
Ziv, Y., Ron, N., Butovsky, O., Landa, G.,
Sudai, E., Greenberg, N., et al. (2006).
Immune cells contribute to the main-
tenance of neurogenesis and spatial
learning abilities in adulthood. Nat.
Neurosci. 9, 268–275.
Ziv, Y., and Schwartz, M. (2008).
Orchestrating brain-cell renewal: the
role of immune cells in adult neuro-
genesis in health and disease. Trends
Mol. Med. 14, 471–478.
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
Frontiers in Cellular Neuroscience www.frontiersin.org April 2013 | Volume 7 | Article 34 | 9
“fncel-07-00034” — 2013/4/5 — 13:16 — page 10 — #10
London et al. Macrophage heterogeneity within the CNS
could be construed as a potential con-
ﬂict of interest.
Received: 30 January 2013; paper pend-
ing published: 04 March 2013; accepted:
18 March 2013; published online: 08
April 2013.
Citation: London A, Cohen M and
Schwartz M (2013) Microglia and
monocyte-derived macrophages: func-
tionally distinct populations that act in
concert in CNS plasticity and repair.
Front. Cell. Neurosci. 7:34. doi: 10.3389/
fncel.2013.00034
Copyright © 2013 London, Cohen and
Schwartz. This is an open-access arti-
cle distributed under the terms of the
Creative Commons Attribution License,
which permits use, distribution and
reproduction in other forums, provided
the original authors and source are cred-
ited and subject to any copyright notices
concerning any third-party graphics etc.
Frontiers in Cellular Neuroscience www.frontiersin.org April 2013 | Volume 7 | Article 34 | 10
